Document is current
Any future updates will be listed below
-
Authors
Watanabe, Hirofumi
Inoue, Yusuke https://orcid.org/0000-0001-8075-0597
Tsuchiya, Kazuo
Asada, Kazuhiro
Suzuki, Makoto
Ogawa, Hiroshi
Tanahashi, Masayuki
Watanabe, Takuya
Matsuura, Shun
Yasuda, Kazuyo
Ohnishi, Ippei
Imokawa, Shiro
Yasui, Hideki
Karayama, Masato https://orcid.org/0000-0003-0455-4070
Suzuki, Yuzo
Hozumi, Hironao https://orcid.org/0000-0001-5439-1543
Furuhashi, Kazuki
Enomoto, Noriyuki
Fujisawa, Tomoyuki
Funai, Kazuhito
Shinmura, Kazuya https://orcid.org/0000-0003-4963-746X
Sugimura, Haruhiko
Inui, Naoki
Suda, Takafumi
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP21K16139, JP23K15205)
Takeda Science Foundation
The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care HUSM Grant-in-Aid
- License Information
-
More Information
Article History
Received: 20 June 2024
Accepted: 28 February 2025
First Online: 13 March 2025
Competing interests
: Yusuke Inoue. Speakers’ Bureau: Chugai Pharmaceutical, AstraZeneca, Takeda Pharmaceutical (outside the submitted work). Kazuhiro Asada. Speakers’ Bureau: Chugai Pharma, AstraZeneca, Eli Lilly, Nippon Boehringer Ingelheim, Merk biopharma, Takeda Pharmaceutical (outside the submitted work). Naoki Inui. Speakers’ Bureau: Chugai Pharma, Eli Lilly, Nippon Boehringer Ingelheim, Novartis, Taiho Pharmaceutical (outside the submitted work). Research Funding: Chugai Pharma, Nippon Boehringer Ingelheim, Taiho Pharmaceutical, AstraZeneca (outside the submitted work). The remaining authors declare no conflict of interest.
